Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Hiroshi Kawashimo"'
Autor:
Tatsuki Ichikawa, Hidetaka Shibata, Daisuke Nishimura, Keisuke Hamasaki, Takashi Goto, Katsumi Eguchi, Hiroshi Kawashimo, Naota Taura, Yasuhide Motoyoshi, Kazuhiko Nakao, Mariko Kusaba
Publikováno v:
Journal of Hepatology. 47:546-555
Background/Aims Signal transducer and activator of transcription 3 (STAT3) is constitutively activated and regulates cell growth and survival of various cancer cells. We investigated the anti-tumor effect of AG490, a Janus kinase 2 specific inhibitor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0995e9fc27123babde7a221f8bb3177f
https://doi.org/10.1016/j.jhep.2007.04.017
https://doi.org/10.1016/j.jhep.2007.04.017
Autor:
Tatsuki Ichikawa, Hidetaka Shibata, Takashi Goto, Koichiro Kusumoto, Norio Abiru, Masumi Fujimoto, Yasuhide Motoyoshi, Daisuke Nishimura, Katsumi Eguchi, Hiroshi Kawashimo, Kazuhiko Nakao, Hironori Yamasaki, Naota Taura, Keisuke Hamasaki, Mariko Fukuta
Publikováno v:
The American Journal of Gastroenterology. 101:2752-2759
Background Several clinical studies have suggested a possible link between chronic hepatitis caused by hepatitis C virus (HCV) and the development of diabetes mellitus. We investigated the association between liver fibrosis and glucose intolerance in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6d9fa06be9a089d14817ceeba27dc8b
https://doi.org/10.1111/j.1572-0241.2006.00835.x
https://doi.org/10.1111/j.1572-0241.2006.00835.x
Autor:
Tatsuki Ichikawa, Masumi Fujimoto, Naota Taura, Hidetaka Shibata, Katsumi Eguchi, Yasuhide Motoyoshi, Hiroshi Kawashimo, Daisuke Nishimura, Kazuhiko Nakao, Keisuke Hamasaki, Mariko Fukuta, Koichiro Kusumoto, Takashi Goto
Publikováno v:
Clinical Gastroenterology and Hepatology. 4:1177-1183
Background & Aims: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. However, although the therapeutic approaches for HCC have progressed rapidly, it remains unknown whether the current management of patients with HCC has re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b551d27881047fd6bb3d15628f0f5117
https://doi.org/10.1016/j.cgh.2006.06.008
https://doi.org/10.1016/j.cgh.2006.06.008
Autor:
Daisuke Nishimura, Tatsuki Ichikawa, Kazuaki Okubo, Hidetaka Shibata, Naota Taura, Takashi Goto, Katsumi Eguchi, Yasuhide Motoyoshi, Kazuhiko Nakao, Keisuke Hamasaki, Mariko Fukuta, Hiroshi Kawashimo
Publikováno v:
Kanzo. 47:329-333
症例は54歳女性．2001年8月B型肝硬変の診断でS病院入院．9月よりラミブジンが開始された．ウイルス量は漸減し2002年8月にはTMA法で検出感度以下となり，肝機能も改善した．2003年1月，ウ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab04495b58efc44c7f35003f9ed4cc76
https://doi.org/10.2957/kanzo.47.329
https://doi.org/10.2957/kanzo.47.329
Autor:
Masumi Fujimoto, Motohisa Akiyama, Tatsuki Ichikawa, Katsumi Eguchi, Hidetaka Shibata, Shigeyuki Takeshita, Hiroshi Kawashimo, Eisuke Ozawa, Yasuhide Motoyoshi, Naota Taura, Kazuhiko Nakao, Satoshi Miuma, Hisamitsu Miyaaki
Publikováno v:
Oncology Reports. 22
Impaired glucose tolerance influences the prognosis of hepatocellular carcinoma (HCC), but this mechanism is still not fully understood. We investigated the impact of the fasting serum levels of insulin and adiponectin on the prognosis of HCC and its
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1edbd4a347835822c062723c3d990e68
https://doi.org/10.3892/or_00000583
https://doi.org/10.3892/or_00000583
Autor:
Keisuke Hamasaki, Mariko Fukuta, Katsumi Eguchi, Tatsuki Ichikawa, Hidetaka Shibata, Kouichiro Kusumoto, Daisuke Nishimura, Kaoru Inokuchi, Takashi Goto, Yasuhide Motoyoshi, Hiroshi Kawashimo, Hisamitsu Miyaaki, Naota Taura, Masumi Fujimoto, Kazuhiko Nakao
Publikováno v:
Oncology Reports.
The incidence of hepatocellular carcinoma (HCC) in Japan has been increasing. The aim of the present study was to analyze epidemiological changes in Japanese HCC patients. A total of 463 patients with HCC diagnosed at our hospital between 1982 and 20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5609bebd2dde69836bda6baebf22009a
https://doi.org/10.3892/or.16.4.837
https://doi.org/10.3892/or.16.4.837
Autor:
Hiroshi Kawashimo, Kazuo Umezawa, Takashi Goto, Tatsuki Ichikawa, Yasuhide Motoyoshi, Katsumi Eguchi, Hidetaka Shibata, Hiroki Ishikawa, Kojiro Matsumoto, Naota Taura, Daisuke Nishimura, Keisuke Hamasaki, Mariko Fukuta, Kazuhiko Nakao
Publikováno v:
International Journal of Oncology.
Several reports have indicated that nuclear factor-kappaB (NF-kappaB) is constitutively activated in a variety of cancer cells including hepatoma cells and plays a key role in their growth and survival. Dehydroxymethylepoxyquinomicin (DHMEQ) derived
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba5f7400d79e8e95a8485aaaffd5adce
https://doi.org/10.3892/ijo.29.3.713
https://doi.org/10.3892/ijo.29.3.713
Autor:
Daisuke, Nishimura, Hiroki, Ishikawa, Kojiro, Matsumoto, Hidetaka, Shibata, Yasuhide, Motoyoshi, Mariko, Fukuta, Hiroshi, Kawashimo, Takashi, Goto, Naota, Taura, Tatsuki, Ichikawa, Keisuke, Hamasaki, Kazuhiko, Nakao, Kazuo, Umezawa, Katsumi, Eguchi
Publikováno v:
International journal of oncology. 29(3)
Several reports have indicated that nuclear factor-kappaB (NF-kappaB) is constitutively activated in a variety of cancer cells including hepatoma cells and plays a key role in their growth and survival. Dehydroxymethylepoxyquinomicin (DHMEQ) derived
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::58e3680ab7b57c1bbebd4f7efd97af23
https://pubmed.ncbi.nlm.nih.gov/16865289
https://pubmed.ncbi.nlm.nih.gov/16865289
Autor:
Katsumi Eguchi, Keisuke Hamasaki, Tatsuki Ichikawa, Takashi Goto, Mariko Fukuta, Hidetaka Shibata, Naota Taura, Hiroshi Kawashimo, Daisuke Nishimura, Yasuhide Motoyoshi, Kazuhiko Nakao
Publikováno v:
Oncology reports. 14(4)
Although there is no definitive evidence that hepatocellular carcinoma (HCC) screening in high-risk groups improves survival, many physicians screen high-risk populations with various tools such as alpha-fetoprotein (AFP) and ultrasonography (USG). T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e364eb493bfcf707a57c0c1846d32db
https://pubmed.ncbi.nlm.nih.gov/16142364
https://pubmed.ncbi.nlm.nih.gov/16142364